HemaSphere (Jun 2022)

S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC MYELOID LEUKEMIA

  • F. Pane,
  • F. Castagnetti,
  • L. Luciano,
  • A. Russo Rossi,
  • E. Abruzzese,
  • R. Bassan,
  • G. Binotto,
  • G. Caocci,
  • G. Cimino,
  • P. Fazi,
  • A. Gozzini,
  • M. Lunghi,
  • R. Marasca,
  • B. Martino,
  • M. Bonifacio,
  • F. Cavazzini,
  • F. Paoloni,
  • G. Saglio,
  • S. Sica,
  • A. Tafuri,
  • D. Vallisa,
  • M. Vignetti,
  • P. Westerweel,
  • G. Rosti,
  • M. Breccia

DOI
https://doi.org/10.1097/01.HS9.0000843516.08806.86
Journal volume & issue
Vol. 6
pp. 57 – 58

Abstract

Read online

No abstracts available.